KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Change in Receivables (2016 - 2025)

Amgen (AMGN) has 17 years of Change in Receivables data on record, last reported at $1.1 billion in Q4 2025.

  • For Q4 2025, Change in Receivables rose 327.27% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $2.7 billion, up 706.8%, while the annual FY2025 figure was $2.7 billion, 706.8% up from the prior year.
  • Change in Receivables reached $1.1 billion in Q4 2025 per AMGN's latest filing, up from -$222.0 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $1.3 billion in Q1 2025 and bottomed at -$486.0 million in Q1 2024.
  • Average Change in Receivables over 5 years is $221.2 million, with a median of $178.0 million recorded in 2022.
  • Peak YoY movement for Change in Receivables: skyrocketed 451.79% in 2022, then plummeted 437.5% in 2024.
  • A 5-year view of Change in Receivables shows it stood at $160.0 million in 2021, then rose by 12.5% to $180.0 million in 2022, then soared by 140.56% to $433.0 million in 2023, then tumbled by 209.24% to -$473.0 million in 2024, then surged by 327.27% to $1.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were $1.1 billion in Q4 2025, -$222.0 million in Q3 2025, and $515.0 million in Q2 2025.